Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DARPA and NIH to Fund ‘Human Body on a Chip’ Research

Published: Wednesday, July 25, 2012
Last Updated: Wednesday, July 25, 2012
Bookmark and Share
MIT-led team to receive up to $32 million to develop technology that could accelerate pace and efficiency of pharmaceutical testing.

Researchers in the Department of Biological Engineering at MIT will receive up to $32 million over the next five years from the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH) to develop a technology platform that will mimic human physiological systems in the laboratory, using an array of integrated, interchangeable engineered human tissue constructs.

A cooperative agreement between MIT and DARPA worth up to $26.3 million will be used to establish a new program titled “Barrier-Immune-Organ: MIcrophysiology, Microenvironment Engineered TIssue Construct Systems” (BIO-MIMETICS) at MIT, in collaboration with researchers at the Charles Stark Draper Laboratory, MatTek Corp. and Zyoxel Ltd. The BIO-MIMETICS proposal was one of two award winners selected as part of the Microphysiological Systems (MPS) program at DARPA, and will be led by MIT professor Linda Griffith in collaboration with MIT professors Steven Tannenbaum, Darrell Irvine, Paula Hammond, Eric Alm and Douglas Lauffenburger. Jeffrey Borenstein and Shankar Sundaram will lead the work at Draper Laboratory, Patrick Hayden will lead the work at MatTek, and David Hughes will lead the work at Zyoxel.

The BIO-MIMETICS program will combine technologies developed at MIT, Draper Laboratory, MatTek and Zyoxel to create a versatile microfluidic platform that can incorporate up to 10 individual engineered human microphysiological organ system modules in an interacting circuit. The modules will be designed to mimic the functions of specific organ systems representing a broad spectrum of human tissues, including the circulatory, endocrine, gastrointestinal, immune, integumentary, musculoskeletal, nervous, reproductive, respiratory and urinary systems. The goal of the program is to create a versatile platform capable of accurately predicting drug and vaccine efficacy, toxicity, and pharmacokinetics in preclinical testing. The BIO-MIMETICS team anticipates that the platform will be suitable for use in regulatory review, amenable to rapid translation to the biopharmaceutical research community, and adaptable for integration of future technologies (such as advances in stem cell technologies and personalized medicine).

A cooperative agreement worth up to $6.25 million from the National Center for Advancing Translational Sciences (NCATS) at NIH will support a complementary research initiative at MIT and Draper Laboratory, in collaboration with professors Alan Wells, Donna Stolz and Raman Venkataramanan at the University of Pittsburgh. The aim of this project is to model cancer metastasis therapies using engineered human tissue constructs, with a goal of adapting this work to the integrated BIO-MIMETICS platform.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

High-Capacity Nanoparticles
New type of nanoparticle can now have three or more drugs packaged within it, allowing for customised cancer therapy.
Thursday, September 15, 2016
Linking RNA Structure and Function
Biologists have deciphered a lncRNA structure and used the information to investigate its cellular protein interactions.
Friday, September 09, 2016
Long-Term Drug Release
New tablet attaches to the lining of the GI tract, resists being pulled away.
Thursday, April 07, 2016
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Friday, January 29, 2016
No More Insulin Injections?
Encapsulated pancreatic cells offer possible new diabetes treatment.
Tuesday, January 26, 2016
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Monday, January 25, 2016
Organ-on-a-Chip
In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues.
Friday, January 08, 2016
How Cancer Cells Spread
Study offers new targets for drugs that may prevent cancer from spreading.
Thursday, December 17, 2015
Delivering microRNAs for Cancer Treatment
Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of breast cancer.
Wednesday, December 09, 2015
Using Ultrasound to Improve Drug Delivery
New approach could aid in treatment of inflammatory bowel disease.
Friday, October 23, 2015
A Metabolic Master Switch Underlying Human Obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Friday, August 21, 2015
Capturing Cell Growth in 3-D
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
Monday, August 17, 2015
Microscopic “Walkers” Find Their Way Across Cell Surfaces
Technology could provide a way to deliver probes or drugs to cell structures without outside guidance.
Thursday, October 23, 2014
Getting Metabolism Right
Analysis of 89 models of metabolic processes finds flaws in 44 of them — but suggests corrections.
Thursday, October 09, 2014
New Drug Candidate Shows Promise Against Cancer
Drugs containing platinum are among the most powerful and widely used cancer drugs. However, such drugs have toxic side effects, and cancer cells can eventually become resistant to them.
Wednesday, July 11, 2012
Scientific News
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Adipose Tissue Secretes Factors That Activate Metabolism
Study finds brown adipose tissue secretes signalling factors that activates metabolism of fat and carbohydrates.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
Developing Novel Ear Infection Treatments
Research team engineers antibiotic gel for treating middle ear infections.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Smart Material Hunts Cancers
Team has created smart material that locates and images cancer or tumour sites in tissue.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Reprogramming Lymph Nodes to Fight MS
Bioengineers work to reprogram lymph node function to fight multiple sclerosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!